KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Labcorp Holdings (LH) Common Equity (2016 - 2025)

Labcorp Holdings' Common Equity history spans 17 years, with the latest figure at $8.7 billion for Q3 2025.

  • For Q3 2025, Common Equity rose 6.45% year-over-year to $8.7 billion; the TTM value through Sep 2025 reached $8.7 billion, up 6.45%, while the annual FY2024 figure was $8.1 billion, 2.25% up from the prior year.
  • Common Equity for Q3 2025 was $8.7 billion at Labcorp Holdings, up from $8.5 billion in the prior quarter.
  • Across five years, Common Equity topped out at $10.7 billion in Q1 2022 and bottomed at $7.9 billion in Q3 2023.
  • The 5-year median for Common Equity is $8.8 billion (2023), against an average of $9.2 billion.
  • The largest annual shift saw Common Equity skyrocketed 43.85% in 2021 before it decreased 23.03% in 2024.
  • A 5-year view of Common Equity shows it stood at $10.3 billion in 2021, then decreased by 1.72% to $10.1 billion in 2022, then decreased by 22.0% to $7.9 billion in 2023, then rose by 2.25% to $8.1 billion in 2024, then rose by 8.01% to $8.7 billion in 2025.
  • Per Business Quant, the three most recent readings for LH's Common Equity are $8.7 billion (Q3 2025), $8.5 billion (Q2 2025), and $8.3 billion (Q1 2025).